邹鑫 刘秀娟 余燕燕
摘 要:目的 观察血液透析对维持性血液透析患者外周血FGF-23水平与钙磷代谢的影响,为慢性肾衰患者调节钙磷水平提供参考。方法 选取2016年6月~2017年6月在本院经低钙透析液行MHD治疗患者35例,于治疗前、治疗1、3、6个月后取血检测患者血清FGF-23及钙磷水平。结果 MHD患者血清FGF-23与磷水平逐渐降低且低于治疗前水平,差异有统计学意义(P<0.05);血钙水平治疗1个月时与治疗前无显著性差异,治疗3个月后开始降低,差异有统计学意义(P<0.05)。结论 血液透析能降低MHD患者血液FGF-23水平及钙、磷水平,且对于血清FGF-23与磷水平的调节作用更快,可作为慢性肾衰患者钙磷调节的有效方法。
关键词:血液透析;FGF-23;钙磷代谢
中图分类号:R692.5 文献标识码:A DOI:10.3969/j.issn.1006-1959.2018.09.036
文章编号:1006-1959(2018)09-0119-02
Abstract:Objective To observe the effect of hemodialysis on peripheral blood FGF-23 levels and calcium and phosphorus metabolism in maintenance hemodialysis patients,and provide reference for the regulation of calcium and phosphorus levels in patients with chronic renal failure.Methods 35 patients with MHD treated with low calcium dialysate in our hospital from June 2016 to June 2017 were selected.Serum FGF-23 and calcium and phosphorus level were measured before 1,3 and 6 months after treatment.Results The levels of serum FGF-23 and phosphorus in MHD patients decreased gradually and were lower than those before treatment,the difference was statistically significant(P<0.05);There was no significant difference in serum calcium levels between 1 month and before treatment,and it began to decrease after 3 months of treatment,the difference was statistically significant(P<0.05). Conclusion Hemodialysis can reduce the blood FGF-23 levels and calcium and phosphorus levels in patients with MHD,and has a faster regulation effect on serum FGF-23 and phosphorus levels,and can be used as an effective method for calcium and phosphorus regulation in patients with chronic renal failure.
Key words:Hemodialysis;FGF-23;Calcium and phosphorus metabolism
慢性肾衰竭(chronic renal failure,CRF)患者需接受长期血液透析治疗,是延长患者生命的一种维持方法。但是维持性血液透析(MHD)对患者机体相关代谢是有负面影响的,常引起患者钙磷代谢紊乱及继发性甲状腺功能亢进,是慢性肾衰竭患者死亡的重要原因[1]。研究发现,血清成纤维细胞生长因子23(FGF-23)是MHD患者发生血管钙化的独立危险因素,通过降低血清FGF-23水平可能是减少MHD患者相关并发症的新思路[2]。临床治疗中血液透析可减轻钙负荷,但这一作用是否患者血清FGF-23水平有关尚不明确。本研究通过观察解放军第九四医院收治的MHD患者血透过程血清FGF-23、钙、磷水平的变化,以探讨血液透析对MHD患者血清FGF-23、钙、磷水平的影响。
1 资料与方法
1.1一般资料 选取2016年6月~2017年6月解放军第九四医院肾内科收治的MHD患者35例,男21例、女14例,年龄28~75岁;其中慢性肾小球肾炎13例、糖尿病肾病9例,慢性小管间质性肾炎8例,紫癜性肾炎3例、痛风性肾病2例。排除恶性肿瘤、急性心脑血管疾病及临床资料不全者,所选研究对象均已签署知情同意书。……